Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Vitamin D Supplementation Activates Genes That Reduce Disease Risk

By BiotechDaily International staff writers
Posted on 08 Apr 2013
Advanced gene scanning microarray technology was used to identify a set of 291 genes linked to 160 biologic pathways that were activated by increased levels of vitamin D.

Vitamin D deficiency (less than 20 ng/mL of 25-hydroxyvitamin D), underlies a number of health issues, including rickets and other musculoskeletal diseases. More recent findings suggest that vitamin D deficiency and vitamin D insufficiency (from 21–29 ng/mL) are associated with various cancers, autoimmune diseases, infectious diseases, type II diabetes, and cardiovascular disease.

Investigators at Boston University School of Medicine (MA, USA) conducted a study to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in white blood cells collected from healthy adults before and two months after daily supplementation with either 400 or 2000 IU vitamin D3.

Results of analysis of white blood cell DNA collected from eight healthy adults during the randomized, double-blind, single center pilot trial were published in the March 20, 2013, online edition of the journal PLOS ONE. They revealed that vitamin D3 supplementation that improved serum 25-hydroxyvitamin D concentrations was associated with at least a 1.5 fold alteration in the expression of 291 genes (from the more than 22,500 genes that were investigated). There was a significant difference in the expression of 66 genes between subjects at baseline with vitamin D deficiency and subjects with normal levels of the vitamin.

Further analysis showed that the biologic functions associated with the 291 genes were related to 160 biologic pathways linked to cancer, autoimmune diseases, infectious diseases, and cardiovascular disease.

"This study reveals the molecular fingerprints that help explain the nonskeletal health benefits of vitamin D," said senior author Dr. Michael F. Holick, professor of medicine, physiology, and biophysics at Boston University School of Medicine. "While a larger study is necessary to confirm our observations, the data demonstrates that improving vitamin D status can have a dramatic effect on gene expression in our immune cells and may help explain the role of vitamin D in reducing the risk for cardiovascular disease, cancer, and other diseases."

Related Links:
Boston University School of Medicine



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission (EC) has approved a new therapeutic option for the most difficult to treat form of ovarian cancer. Ovarian cancer causes more deaths... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel
Image: The DrySyn MULTI converts any standard hotplate stirrer into a high performance reaction block (Photo courtesy of Asynt).

New Reaction Vessel Heating System Is Cleaner and Safer

Biotech and other life science researchers can create a safer, cleaner, and more efficient working environment in their laboratories by switching from oil bath-based heating of reaction vessels to a new... Read more

Business

view channel

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research. Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.